Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Hruska
J. Hruska
Novartis
Canakinumab
Physical therapy
Medicine
Discontinuation
Pediatrics
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial
2013
Annals of the Rheumatic Diseases
N Ruperto
Hermine I. Brunner
Tamás Constantin
N Wulffraat
G. Horneff
J Anton
Reinhard Berner
Fabrizia Corona
Ruben Cuttica
M Desjonqueres
Michael Fischbach
M. Alessio
A Chieng
Emminger W
Elie Haddad
K. Lheritier
Ken Abrams
J. Hruska
D. Kim
A. Martini
Daniel J. Lovell
Show All
Source
Cite
Save
Citations (1)
PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
2013
Pediatric Rheumatology
Pierre Quartier
Hi Brunner
Tamás Constantin
Shai Padeh
Inmaculada Calvo
Muferet Erguven
L. Goffin
Michael Hofer
Tilmann Kallinich
Sheila Knupp Feitosa de Oliveira
Yosef Uziel
Stefania Viola
K. Nistala
Carine Wouters
K. Lheritier
J. Hruska
Ken Abrams
A. Martini
N Ruperto
D Lovell
Show All
Source
Cite
Save
Citations (1)
1